Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Trading Statement

24 May 2011 07:00

RNS Number : 1517H
China Private Equity Inv Hldgs Ld
24 May 2011
Β 

ο»Ώ

24 May 2011

Β 

Β 

Β 

China Private Equity Investments Holdings Limited

("CPE" or the "Company")

Β 

Notice of Final Results and Trading Update

Β 

Β 

The Company's principal activity is to invest in growth companies operating in Greater China.

Β 

Β 

The Board of CPE (AIM: CPEH) today announces that final results for the year to 31 December 2010 will be published in the second week of June 2011 and provides shareholders with a trading update for the period to end April 2011.

Β 

Trading Update

Β 

Net assets at 31 December 2010 are expected to be approximately US$28.5 million (2009: US$27.4 million). Net asset value per share at that date is expected to be approximately US$0.44 (2009: US$0.43, adjusted for the four for one bonus issue). Profit after tax for the year to 31 December 2010 is expected to be approximately US$1.8 million (2009: US$2.5 million), reflecting a smaller relative increase in fair value of our 37% holding in Fortel Technology Holdings Limited ("Fortel") in 2010 compared to 2009. The Company anticipates that such fluctuations will even out as its portfolio mix continues to expand in line with its steady progress over the course of the past 16 months.

Β 

Within our investment portfolio, the strong 2010 performance by Fortel, a digital media andΒ technology services company operating in mainland China has continued into the current year, and it last month repurchasedΒ some of its own shares from the Company. The repurchase price of US$690.50 per share valued Fortel at US$72 million in total, and CPE now retains a 33.60% stake. The Company will use the US$3.8 million raised by the transaction to provide further funding for investing in additional opportunities.

Β 

Fortel's plans for a listing on the Hong Kong Stock Exchange later this year remain on course.

Β 

In November 2010, the Company further positioned itself for continued growth with the acquisition of a 40% interest in Beijing based China iEducation Group for a total consideration of US$2 million. Involved in the development and distribution of digital education content to elementary and middle schools in mainland China, China iEducation Group has been profitable since 2008 and is working with CPE to implement a long-term expansion strategy.

Β 

Post the Company's year end, in March 2011, CPE announced an agreement to acquire up to a 30% stake in Hong Kong-based Enfinium InternationalΒ Holdings Limited ("Enfinium"), a leading online financial services business, for a total consideration of US$6 million, satisfied by the issue of 10 million new CPE ordinary shares of no par value at a price of US$ 0.60 per share. Enfinium represents a strategic investment intended simultaneously to broaden CPE's exposure to online opportunities and provide direct access to Enfinium's global network of private equity investors.

Β 

Established in 2007, Enfinium provides its clients with a global online trading platform that allows them to trade stocks on most of the world's stock exchanges, along with foreign exchange, futures and other transactions. It has a wide network of high net worth investors who are seeking access to Chinese investment opportunities such as those sourced by CPE. For the twelve months ending 28 February 2011, Enfinium generated pre-tax profits of approximately US$2.5 million. As at 28 February 2011, the business had unaudited net assets of approximately US$3.5 million. The trading in the last three months has been well ahead of the same period last year, and the business is expecting to substantially outperform 2010.

Β 

The Company's investment strategy is to provide shareholders with an attractive return on their investment through capital appreciation, by investing in businesses doing business in or with China which are likely to achieve a trade sale or an IPO, predominantly within a medium to long term time horizon. The Directors believe that the Company's current portfolio of investments will generate such returns and that CPE is on course to deliver its objectives for shareholders.

Β 

Commenting, Duncan Chui, CEO, said, "In addition to our flagship investment in Fortel, we have successfully sourced a number of exciting opportunities that we consider to have the potential to generate significant capital appreciation for shareholders. 2011 will see further progress towards our objectives."

Β 

For further information, please visit www.cpe-invest.com or contact:

Β 

China Private Equity Investments Holdings Limited

+852 2801 6770

Duncan Chui, CEO / Ernest Wong, CFO

Shore Capital and Corporate Limited (Nominated Adviser)

+44 (0)20 7408 4090

Stephane Auton

Tavistock / First City Public Relations

Allan Piper

+852 2854 2666

Simon Hudson / Lydia Eades

+44 (0) 20 7920 3150

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTGXGDUIXDBGBS
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.